Strategies and safeguards to ensure access to long-acting reversible contraception removal after the Zika Contraception Access Network ended: A prospective analysis of patient reported complaints.


Journal

Contraception
ISSN: 1879-0518
Titre abrégé: Contraception
Pays: United States
ID NLM: 0234361

Informations de publication

Date de publication:
11 2020
Historique:
received: 01 05 2020
revised: 13 08 2020
accepted: 14 08 2020
pubmed: 29 8 2020
medline: 16 10 2021
entrez: 29 8 2020
Statut: ppublish

Résumé

The Zika Contraception Access Network (Z-CAN) was a short-term emergency response intervention that used contraception to prevent unintended pregnancy to reduce Zika-related adverse birth outcomes during the 2016 2017 Zika virus outbreak in Puerto Rico. Strategies and safeguards were developed to ensure women who chose long-acting reversible contraception (LARC) had access to no-cost removal, if desired, after Z-CAN ended. We assessed the number of women who chose LARC at their initial Z-CAN visit who filed complaints regarding challenges with LARC removal within 30-months after the Z-CAN program ended. Complaints and program responses were categorized. Of the 29,221 women who received Z-CAN services, 20,381 chose a LARC method at their initial visit (IUD = 12,276 and implant = 8105). Between September 2017 and February 2020, 63 patient complaints were logged, mostly due to LARC removal charges (76.2%) which were generally (71.4%) determined to be inappropriate charges. All complaints filed were resolved allowing LARC removal within an average of 28 days. Safeguards to ensure prompt LARC removal when desired are critical to ensure women s reproductive autonomy. Strategies and safeguards used by Z-CAN to ensure women have access to LARC removal might be used by other contraception programs to prevent reproductive coercion and promote reproductive autonomy to best meet the reproductive needs of women.

Identifiants

pubmed: 32858052
pii: S0010-7824(20)30331-0
doi: 10.1016/j.contraception.2020.08.008
pmc: PMC7606820
mid: NIHMS1631319
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

356-360

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Références

Demography. 1986 Aug;23(3):351-65
pubmed: 3758445
Fertil Steril. 1988 Jun;49(6):973-81
pubmed: 3259513
Am J Public Health. 2016 Nov;106(11):1932-1937
pubmed: 27631741
Am J Public Health. 2016 Jan;106(1):18-9
pubmed: 26562116
MMWR Morb Mortal Wkly Rep. 2016 Apr 01;65(12):311-4
pubmed: 27031817
Lancet Public Health. 2018 Feb;3(2):e91-e99
pubmed: 29371100
Birth Defects Res. 2019 Aug 1;111(13):938-940
pubmed: 31264801
Perspect Sex Reprod Health. 2014 Sep;46(3):171-5
pubmed: 24861029
Am J Public Health. 2018 Sep;108(S3):S227-S230
pubmed: 30192658
Am J Med Qual. 2013 Jul-Aug;28(4):339-44
pubmed: 23092934
Womens Health Issues. 2017 May - Jun;27(3):253-255
pubmed: 28476290
Obstet Gynecol. 2020 May;135(5):1095-1103
pubmed: 32282596

Auteurs

Lisa Romero (L)

Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, United States. Electronic address: eon1@cdc.gov.

Zipatly Mendoza (Z)

National Foundation for the Centers for Disease Control and Prevention, United States.

Stacey Hurst (S)

Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, United States.

Lauren B Zapata (LB)

Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, United States.

Rachel Powell (R)

National Foundation for the Centers for Disease Control and Prevention, United States.

Yari Vale (Y)

University of Puerto Rico, Department of Gynecology and Obstetrics, United States.

Eva Lathrop (E)

Emory University, Department of Gynecology and Obstetrics, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH